Literature DB >> 9789069

Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK.

C Takahashi1, Z Sheng, T P Horan, H Kitayama, M Maki, K Hitomi, Y Kitaura, S Takai, R M Sasahara, A Horimoto, Y Ikawa, B J Ratzkin, T Arakawa, M Noda.   

Abstract

A human fibroblast cDNA expression library was screened for cDNA clones giving rise to flat colonies when transfected into v-Ki-ras-transformed NIH 3T3 cells. One such gene, RECK, encodes a membrane-anchored glycoprotein of about 110 kDa with multiple epidermal growth factor-like repeats and serine-protease inhibitor-like domains. While RECK mRNA is expressed in various human tissues and untransformed cells, it is undetectable in tumor-derived cell lines and oncogenically transformed cells. Restored expression of RECK in malignant cells resulted in suppression of invasive activity with concomitant decrease in the secretion of matrix metalloproteinase-9 (MMP-9), a key enzyme involved in tumor invasion and metastasis. Moreover, purified RECK protein was found to bind to, and inhibit the proteolytic activity of, MMP-9. Thus, RECK may link oncogenic signals to tumor invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9789069      PMCID: PMC23764          DOI: 10.1073/pnas.95.22.13221

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.

Authors:  C Takahashi; N Akiyama; T Matsuzaki; S Takai; H Kitayama; M Noda
Journal:  Oncogene       Date:  1996-05-16       Impact factor: 9.867

Review 2.  Oncoprotein networks.

Authors:  T Hunter
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

Review 3.  Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic.

Authors:  W G Stetler-Stevenson; R Hewitt; M Corcoran
Journal:  Semin Cancer Biol       Date:  1996-06       Impact factor: 15.707

4.  A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor.

Authors:  K Miyazaki; M Hasegawa; K Funahashi; M Umeda
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

5.  Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B.

Authors:  H Kobayashi; H Ohi; M Sugimura; H Shinohara; T Fujii; T Terao
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

6.  Pharmacological inhibition of gelatinase B induction and tumor cell invasion.

Authors:  J I McMillan; R Weeks; J W West; S Bursten; G C Rice; D H Lovett
Journal:  Int J Cancer       Date:  1996-08-07       Impact factor: 7.396

7.  Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

Authors:  P C Brooks; S Strömblad; L C Sanders; T L von Schalscha; R T Aimes; W G Stetler-Stevenson; J P Quigley; D A Cheresh
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

8.  Interactions of Streptomyces serine-protease inhibitors with Streptomyces griseus metalloendopeptidase II.

Authors:  K Kajiwara; A Fujita; H Tsuyuki; T Kumazaki; S Ishii
Journal:  J Biochem       Date:  1991-09       Impact factor: 3.387

9.  Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.

Authors:  H J Cha; S K Bae; H Y Lee; O H Lee; H Sato; M Seiki; B C Park; K W Kim
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

10.  A matrix metalloproteinase expressed on the surface of invasive tumour cells.

Authors:  H Sato; T Takino; Y Okada; J Cao; A Shinagawa; E Yamamoto; M Seiki
Journal:  Nature       Date:  1994-07-07       Impact factor: 49.962

View more
  136 in total

1.  Low expression of RECK indicates a shorter survival for patients with invasive breast cancer.

Authors:  Yue Zhang; Shaoqiang Cheng; Guoqiang Zhang; Wenjie Ma; Yang Liu; Rui Zhao; Qingyuan Zhang; Da Pang
Journal:  Cancer Sci       Date:  2012-04-19       Impact factor: 6.716

2.  The metalloproteinase inhibitor Reck is essential for zebrafish DRG development.

Authors:  Andrew Prendergast; Tor H Linbo; Tanya Swarts; Josette M Ungos; Hillary F McGraw; Shlomo Krispin; Brant M Weinstein; David W Raible
Journal:  Development       Date:  2012-02-01       Impact factor: 6.868

Review 3.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

4.  Estrogen suppresses expression of the matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs (RECK) within the mouse uterus.

Authors:  Xuan Zhang; Caitlin Healy; Warren B Nothnick
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

5.  Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.

Authors:  N Namwat; J Puetkasichonpasutha; W Loilome; P Yongvanit; A Techasen; A Puapairoj; B Sripa; W Tassaneeyakul; N Khuntikeo; S Wongkham
Journal:  J Gastroenterol       Date:  2010-11-13       Impact factor: 7.527

6.  Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis.

Authors:  P L E M van Lent; P N Span; A W Sloetjes; T R D J Radstake; A W T van Lieshout; J J T M Heuvel; C G J Sweep; W B van den Berg
Journal:  Ann Rheum Dis       Date:  2004-10-14       Impact factor: 19.103

7.  Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer.

Authors:  Kamdeo K Pramanik; Abhay K Singh; Manzar Alam; Tanushree Kashyap; Prajna Mishra; Aditya K Panda; Ratan K Dey; Ajay Rana; Siddavaram Nagini; Rajakishore Mishra
Journal:  Tumour Biol       Date:  2016-09-30

8.  Impact of Reck expression and promoter activity in neuronal in vitro differentiation.

Authors:  Marina Trombetta-Lima; Thais Assis-Ribas; Ricardo C Cintra; Joana D Campeiro; Juliano R Guerreiro; Sheila M B Winnischofer; Isis C C Nascimento; Henning Ulrich; Mirian A F Hayashi; Mari C Sogayar
Journal:  Mol Biol Rep       Date:  2021-02-22       Impact factor: 2.316

9.  Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK.

Authors:  Jalahalli M Siddesha; Anthony J Valente; Siva S V P Sakamuri; Tadashi Yoshida; Jason D Gardner; Naveen Somanna; Chiaki Takahashi; Makoto Noda; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2013-10-02       Impact factor: 5.000

10.  Expression of matrix metalloproteinases-2 and -9 and RECK during alveolar bone regeneration in rat.

Authors:  Thais Accorsi-Mendonça; Katiúcia Batista da Silva Paiva; Willian Fernando Zambuzzi; Tânia Mary Cestari; Vanessa Soares Lara; Mari Cleide Sogayar; Rumio Taga; José Mauro Granjeiro
Journal:  J Mol Histol       Date:  2007-11-07       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.